The Drug Patent Two-Step
Drug companies are willing to try everything to keep their valuable patents alive.
Drug companies are willing to try everything to keep their valuable patents alive.
Here are three big reasons why, according to IP columnist Tom Kulik.
Explore the mindset, cultural shifts, and training strategies that define the AI‑savvy lawyer, revealing why human judgment, standardized competence, and integrated learning—not technology alone—will shape the future of the profession.
Which law firms were at the top of our patent category through Q3 2017?
If this tactic is allowed, it will be a big win for Big Pharma -- and a big loss for patients and consumers.
When the underlying technology is so potentially valuable, companies will go to war on multiple fronts.
Here's what you need to know in 2017, in an easily consumable way.
Legal work isn’t slowing down, and the firms that win won’t be the ones working harder — they’ll be the ones working smarter.